IQVIA Stock Forecast
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
Market open · Delayed 15 min · as of Oct 9, 1:57 PM ET
IQV analyst consensus
Consensus (22 analysts)
strong_buy
Avg. price target
$290.84+10.95%
- Strong buy 3
- Buy 16
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 22 Wall Street analysts covering IQVIA (2026-10-07), 19 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $290.84, with a high estimate of $345.00 and a low estimate of $250.00. The average target implies upside of 10.9% from the current price of $262.14.
The spread between the highest and lowest targets is 38.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for IQV.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 14% |
| Buy | 16 | 73% |
| Hold | 3 | 14% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $250.00 | -4.63% |
| Average target | $290.84 | +10.95% |
| High target | $345.00 | +31.61% |